Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Markers for Alzheimer disease are reported
October 25th, 2006
A study from Germany describes the evaluation of the temporal horn index and volume of medial temporal lobe atrophy using a new semiautomated method for rapid and precise assessment. "Quantitative markers of Alzheimer disease (AD), particularly in the early stages, are needed for clinical assessment and monitoring. We have evaluated a novel method to segment and visualize the ventricular system and obtain volumetric measures thereof," wrote F.L. Giesel and colleagues of the Deutsch Krebsforschungszentrum. "The temporal horn volume (THV) and index in patients with mild cognitive impairment (MCI) and in those with AD were evaluated. High-resolution...
Source: Biotech Week (2006-10-25)
|
